Staphylococcus aureus and Escherichia hermanii in Diabetes Patient

1. Sichel LS, Greenko J, Heffernan R, Weiss D. Field investigations of emergency department syndromic surveillance signals, New York City. Presentation at the 2003 National Syndromic Surveillance Conference [cited 2004 Jan]. Available from: http://www.syndromic.org/pdf/con2LS-8b.pdf 2. Sosin DM. Syndromic surveillance: the case for skillful investment. Biosecur Bioterror. 2003;1:247–53. 3. Centers for Disease Control and Prevention. Global progress toward certifying polio eradication and laboratory containment of wild polioviruses, August 2002–August 2003. MMWR.2003;52: 1158–60. 4. Centers for Disease Control and Prevention. Public health dispatch: update: fatal and severe liver injuries associated with rifampin and pyrazinamide treatment for latent tuberculosis infection. MMWR Morb Mortal Wkly Rep. 2002;51:998–9. 5. Tan CG, Sandhu HS, Crawford DC, Redd SC, Beach MJ, Buehler JW, et al. Surveillance for anthrax cases associated with contaminated letters, New Jersey, Delaware, and Pennsylvania, 2001. Emerg Infect Dis. 2002;8:1073–7. 6. UNAIDS/WHO Working Group on Global HIV/AIDS/STI Surveillance. Guidelines for sexually transmitted infections surveillance [monograph on the Internet]. 1999 [cited 2004 Jan]. Available from: http: //www.who.int/emc-documents/STIs/docs/ whocdscsredc993.pdf 7. Osterholm MT, Forfang JC. Toxic-shock syndrome in Minnesota: results of an active-passive surveillance system. J Infect Dis. 1982;145:458–64. 8. Centers for Disease Control and Prevention. Current trends update on acquired immune deficiency syndrome (AIDS)—United States. MMWR Morb Mortal Wkly Rep. 1982;31:507–8, 513–4. 9. Centers for Disease Control and Prevention. Outbreak of severe acute respiratory syndrome—worldwide, 2003. MMWR Morb Mortal Wkly Rep. 2003;53:226–8. 10. Centers for Disease Control and Prevention. Framework for evaluating public health surveillance systems for early detection of outbreaks; recommendations from the CDC working group. MMWR. 2004;53(No. RR-5):1–11.